Pseudo‐phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline
- 1 January 1995
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 42 (1) , 95-98
- https://doi.org/10.1111/j.1365-2265.1995.tb02604.x
Abstract
Summary: A patient presented with paroxysmal hypertension and typical clinical features of phaeochromocytoma, but with a normal adrenal computed tomographic scan and much higher plasma noradrenaline than adrenaline concentrations. Urinary vanillyimandelic acid concentrations were only moderately elevated. This syndrome probably arose as a consequence of an interaction between the monoamine oxidase inhibitor selegiline, the sympathomimetic agent ephedrine, and a tricyclic antidepressant The mechanism of the interaction is thought to be related to increased sympathetic release of noradrenaline by ephedrine, inhibition of catabolism by selegiline, and inhibition of reuptake of noradrenaline by the tricyclic. Although newer selective monoamine oxidase inhibitors are considered to be safer than earlier non‐selective inhibitors, they can also contribute to drug intersections mimicking phaeochromocytoma.Keywords
This publication has 17 references indexed in Scilit:
- Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdosesThe Lancet, 1993
- MoclobemideThe Lancet, 1993
- Life-threatening pseudophaeochromocytoma after toloxatone, terbutaline, and phenylephrineThe Lancet, 1993
- Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegilineThe Lancet, 1993
- Serotonin syndrome caused by a moclobemide-clomipramine interaction.BMJ, 1993
- An update of recent moclobemide interaction dataInternational Clinical Psychopharmacology, 1993
- Modulation of Noradrenaline Release by Activation of Presynaptic β‐Adrenoceptors in the Cardiovascular SystemaAnnals of the New York Academy of Sciences, 1990
- Deprenyl as Symptomatic Therapy in Parkinsonʼs DiseaseClinical Neuropharmacology, 1988
- Stereochemical aspects of MAO interactions: reversible and selective inhibitors of monoamine oxidaseTrends in Pharmacological Sciences, 1985
- The inhibition of tyramine oxidation and the tyramine hypertensive response (?cheese effect?) may be independent phenomenaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980